Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Aug 26;18(3):414–422. doi: 10.1016/j.bbmt.2011.08.016

Figure 2.

Figure 2

Correlation of mean week 2 CNI concentrations in patients treated with CSP (A and C) or TAC (B and D) with the maximal change in GFR during the first 4 weeks after HCT with myeloablative conditioning (A and B) or nonmyeloablative conditioning (C and D).